About M2i Life Sciences
M2i Life Sciences is a company based in Saint-cloud (France) founded in 2012 by Bruno Geny and Philippe Guerret. M2i Life Sciences has raised $79.43 million across 2 funding rounds from investors including Eurazeo, Idinvest Partners and Fondation de France. M2i Life Sciences offers products and services including Lobesia Pro Clip and Pheromone Applications. M2i Life Sciences operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Saint-cloud, France
- Founders Bruno Geny, Philippe Guerret
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$79.43 M (USD)
in 2 rounds
-
Latest Funding Round
$66 M (USD), Series B
Sep 03, 2019
-
Investors
Eurazeo
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of M2i Life Sciences
M2i Life Sciences offers a comprehensive portfolio of products and services, including Lobesia Pro Clip and Pheromone Applications.
Two-in-one solution for controlling vineyard pests.
Techniques for natural pest control in agriculture.
People of M2i Life Sciences
Unlock access to complete
Funding Insights of M2i Life Sciences
M2i Life Sciences has successfully raised a total of $79.43M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $66 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in M2i Life Sciences
M2i Life Sciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurazeo, Idinvest Partners and Fondation de France.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private credit, direct lending, and sustainability-focused finance services in Asia Pacific.
|
Locked | Locked | Locked | |
|
Private equity and debt investments are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Private equity firm focused on energy, financial services, agriculture, and hospitality services
|
Locked | Locked | Locked |
Investor details for M2i Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by M2i Life Sciences
Investment portfolio details for M2i Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - M2i Life Sciences
Detailed financials for M2i Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
M2i Life Sciences Comparisons
Peer comparison for M2i Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of M2i Life Sciences
M2i Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of M2i Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on M2i Life Sciences
Complete news archive for M2i Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about M2i Life Sciences
M2i Life Sciences was founded in 2012 and raised its 1st funding round 5 years after it was founded.
M2i Life Sciences is headquartered in Saint-cloud, France.
Philippe Guerret is the current CEO of M2i Life Sciences. They have also founded this company.
M2i Life Sciences is a funded company, having raised a total of $79.43M across 2 funding rounds to date.
M2I Life Sciences was established in 2012 in Saint Cloud, France, within the life sciences sector. Operations span pharmaceutical, veterinary, and agricultural fields. Active pharmaceutical ingredients and pheromones for crop protection and animal health are developed and supplied. Custom synthesis and contract manufacturing services are extended to clients. Pheromonal molecules are synthesized, alongside chemicals including ceramides, antioxidants, and alkylglycerols.
M2i Life Sciences's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
M2i Life Sciences offers Lobesia Pro Clip and Pheromone Applications.
M2i Life Sciences has 6 investors. Key investors include Eurazeo, Idinvest Partners, Fondation de France, ADM Capital, and Tethys Investments.